Amgen Announces Deal With Glaxo - New York Times

stv.tv

Amgen Announces Deal With Glaxo New York Times By REUTERS NEW YORK (Reuters) - Amgen reported much better-than-expected second-quarter earnings, helped by a rebound in sales of its rheumatoid arthritis ... Amgen quarterly profit tops StreetReuters Amgen 2Q Profits Rise 40%; Boosts 2009 View >AMGNWall Street Journal Amgen 2Q profit rises 40 percent on lower costsThe Associated Press Los Angeles Business Journal -PR Newswire (press release) -Wall Street Journal all 204 news articles »

Rigel skids on rheumatoid arthritis drug failure - Forbes

Rigel skids on rheumatoid arthritis drug failure Forbes ... Pharmaceuticals Inc. fell Friday after the company said its drug candidate R788 failed in a clinical trial as a treatment for rheumatoid arthritis. ...

Injecting Value Into Medical Decisions - Wall Street Journal

Injecting Value Into Medical Decisions Wall Street Journal Which of eight expensive drugs for rheumatoid arthritis work best and are worth the potentially harsh side effects? What works best to treat low back pain ... and more »

Rigel Pharma Jumps On Results From Rheumatoid Arthritis Drug - Wall Street Journal

The Money Times

Rigel Pharma Jumps On Results From Rheumatoid Arthritis Drug Wall Street Journal ... data on its second mid-stage study on its treatment for rheumatoid arthritis and saying it hopes to have a partner in place by the first half of 2010. ... Rigel says arthritis drug shows progress; shares soarReuters Rigel shares rise on positive arthritis studyForbes Rigel Pharma's Oral Rheumatoid Arthritis Drug Passes Mid-stage ...RTT News TheStreet.com -MarketWatch all 66 news articles »